REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COMMON STOCK
Shares outstanding
104,986,330
Total 13F shares
72,038,036
Share change
+193,036
Total reported value
$29,554,336,522
Put/Call ratio
134%
Price per share
$410.25
Number of holders
506
Value change
+$161,167,975
Number of buys
225
Number of sells
231

Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2014

As of 31 Dec 2014 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 506 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 72,038,036 shares of stock of the company.
Largest 10 holders included Capital World Investors, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, SANDS CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, State Street Corp, Artisan Partners Limited Partnership, BlackRock Institutional Trust Company, N.A., and BlackRock Fund Advisors.
This table shows 506 institutional shareholders of the security as of 31 Dec 2014.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.